Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Neogenomics appointed Warren Stone as Chief Executive Officer effective January 4, 2027. Tony Zook will transition to Executive Chairman on the same date. Lynn Tetrault will step down as Board Chair, and Michael Kelly becomes Lead Independent Director.
NeoGenomics has appointed President and COO Warren Stone as CEO and a board member, effective Jan. 4, 2027. Stone, 54, previously held senior roles at Ortho Clinical Diagnostics and MilliporeSigma/Merck KGaA.
NeoGenomics announced a succession plan: Warren Stone will become CEO on Jan 4, 2027, with Tony Zook moving to Executive Chair. The company also expects preliminary Q3 revenue of $209 million and reiterated full-year guidance.